ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 152 filers reported holding ANI PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 9.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $497,342 | -13.5% | 8,566 | -19.8% | 0.00% | – |
| Q2 2023 | $574,743 | +129.9% | 10,677 | +69.6% | 0.00% | – |
| Q1 2023 | $250,037 | -22.0% | 6,295 | -21.0% | 0.00% | – |
| Q4 2022 | $320,673 | +43.8% | 7,971 | +14.9% | 0.00% | – |
| Q3 2022 | $223,000 | -3.9% | 6,935 | -11.4% | 0.00% | – |
| Q2 2022 | $232,000 | -34.1% | 7,825 | -37.5% | 0.00% | – |
| Q1 2022 | $352,000 | -11.6% | 12,516 | +44.9% | 0.00% | – |
| Q4 2021 | $398,000 | +103.1% | 8,635 | +44.8% | 0.00% | – |
| Q3 2021 | $196,000 | -15.2% | 5,962 | -9.4% | 0.00% | – |
| Q2 2021 | $231,000 | +335.8% | 6,583 | +350.3% | 0.00% | – |
| Q1 2021 | $53,000 | -41.1% | 1,462 | -52.9% | 0.00% | – |
| Q4 2020 | $90,000 | +23.3% | 3,106 | +19.8% | 0.00% | – |
| Q3 2020 | $73,000 | -61.8% | 2,593 | -56.1% | 0.00% | – |
| Q2 2020 | $191,000 | -31.5% | 5,901 | -13.8% | 0.00% | – |
| Q1 2020 | $279,000 | -51.5% | 6,848 | -26.6% | 0.00% | – |
| Q4 2019 | $575,000 | -90.8% | 9,335 | -89.2% | 0.00% | -100.0% |
| Q3 2019 | $6,282,000 | +350.3% | 86,206 | +408.0% | 0.01% | +400.0% |
| Q2 2019 | $1,395,000 | +498.7% | 16,970 | +412.8% | 0.00% | – |
| Q1 2019 | $233,000 | -88.9% | 3,309 | -92.9% | 0.00% | -100.0% |
| Q4 2018 | $2,108,000 | -23.1% | 46,820 | -3.4% | 0.00% | 0.0% |
| Q3 2018 | $2,740,000 | +76.0% | 48,474 | +108.0% | 0.00% | +100.0% |
| Q2 2018 | $1,557,000 | -35.2% | 23,305 | -43.5% | 0.00% | -50.0% |
| Q1 2018 | $2,401,000 | +2.9% | 41,240 | +14.0% | 0.00% | +100.0% |
| Q4 2017 | $2,333,000 | +34.2% | 36,177 | +9.2% | 0.00% | 0.0% |
| Q3 2017 | $1,739,000 | +91.7% | 33,130 | +70.8% | 0.00% | 0.0% |
| Q2 2017 | $907,000 | -40.3% | 19,394 | -36.7% | 0.00% | 0.0% |
| Q1 2017 | $1,518,000 | -38.6% | 30,646 | -24.9% | 0.00% | -50.0% |
| Q4 2016 | $2,472,000 | +240.5% | 40,782 | +272.9% | 0.00% | +100.0% |
| Q3 2016 | $726,000 | +153.8% | 10,937 | +113.5% | 0.00% | – |
| Q2 2016 | $286,000 | -39.9% | 5,123 | -63.8% | 0.00% | -100.0% |
| Q1 2016 | $476,000 | +2405.3% | 14,156 | +3215.2% | 0.00% | – |
| Q4 2015 | $19,000 | -48.6% | 427 | -54.2% | 0.00% | – |
| Q3 2015 | $37,000 | -19.6% | 932 | +25.8% | 0.00% | – |
| Q2 2015 | $46,000 | -93.0% | 741 | -92.9% | 0.00% | -100.0% |
| Q1 2015 | $657,000 | -9.9% | 10,501 | -18.8% | 0.00% | 0.0% |
| Q4 2014 | $729,000 | +10314.3% | 12,926 | +4669.7% | 0.00% | – |
| Q3 2014 | $7,000 | +75.0% | 271 | +150.9% | 0.00% | – |
| Q2 2014 | $4,000 | – | 108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |